Document is current
Any future updates will be listed below
-
Authors
Diez, Begoña
Genovese, Pietro
Roman‐Rodriguez, Francisco J
Alvarez, Lara
Schiroli, Giulia
Ugalde, Laura
Rodriguez‐Perales, Sandra
Sevilla, Julian
Diaz de Heredia, Cristina
Holmes, Michael C
Lombardo, Angelo
Naldini, Luigi https://orcid.org/0000-0002-7835-527X
Bueren, Juan Antonio https://orcid.org/0000-0002-3228-7013
Rio, Paula https://orcid.org/0000-0002-5424-5543
-
Funding
Funding for this research was provided by:
Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III (RD12/0019/0023)
European Commission's 7th Framework Program (HEALTH‐F5‐2012‐305421)
Ministerio de Economía, Comercio y Competitividad y Fondo Europeo de Desarrollo Regional (SAF2015‐68073‐R)
Rocket Pharma
Ministerio de Sanidad, Servicios Sociales e Igualdad (EC11/060)
Ministerio de Sanidad, Servicios Sociales e Igualdad (EC11/559)
- License Information
-
More Information
Article History
Received: 15 January 2017
Revised: 9 August 2017
Accepted: 14 August 2017
First Online: 12 September 2017
Conflict of interest
: M.C.H. is a current employee of Sangamo Therapeutics, Inc. The Division of Hematopoietic Innovative Therapies receives funding from Rocket Pharma. The rest of the authors declare no competing financial interests.
